跳至主要内容
临床试验/EUCTR2004-000822-58-IT
EUCTR2004-000822-58-IT进行中(未招募)不适用

A double-blind, randomized study of clopidogrel 75 mg/d vs placebo,on a background of ASA 75-100 mg/d,in peripheral arterial disease (PAD) patients receiving a unilateral below knee bypass graft.The CASPAR 2004 study(Clopidogrel and Acetyl salicylic acid in bypass Surgery for Peripheral ARterial disease)

BRISTOL-M.SQUIBB0 个研究点开始时间: 2004年9月15日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) no
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • 未提供

研究者

发起方
BRISTOL-M.SQUIBB

相似试验

进行中(未招募)
不适用
A double blind randomized study of Clopidogrel 75 mg/d versus placebo on a background of ASA 75-100 mg/d, in peripheral disease (PAD) patient receiving a unilateral below knee by-pass graft. - CASPAR 2004MedDRA version: 7.0Level: 1Classification code 10062585
EUCTR2004-000822-58-SESanofi-Synthelabo Groupe1,460
进行中(未招募)
1 期
A double blind randomized study of Clopidogrel 75 mg/d versus placebo on a background of ASA 75-100 mg/d, in peripheral arterial disease (PAD) patients receiving a unilateral below knee by-pass graft - CASPAR 2004Peripheral arterial diseaseMedDRA version: 7.0Level: 1Classification code 10062585
EUCTR2004-000822-58-FIsanofi-synthelabo groupe1,460
进行中(未招募)
1 期
a double blind randomized study of Clopidogrel 75 mg/d versus placebo on a background of ASA 75-100 mg/d, in peripheral disease (PAD) patient receiving a unilateral below knee by-pass graft - CASPAR 2004Enfermedad arterial periferica oclusiva.MedDRA version: 7.0Level: 1Classification code 10062585
EUCTR2004-000822-58-ESsanofi-synthelabo groupe1,460
进行中(未招募)
不适用
a double blind randomized study of Clopidogrel 75 mg/d versus placebo on a background of ASA 75-100 mg/d, in peripheral disease (PAD) patient receiving a unilateral below knee by-pass graft - CASPAR 2004MedDRA version: 7.0Level: 1Classification code 10062585
EUCTR2004-000822-58-HUsanofi-synthelabo groupe1,460
已完成
3 期
CASPAR : Clopidogrel and Acetyl Salicylic Acid in Bypass Surgery for Peripheral ARterial DiseaseArterial Occlusive Diseases
NCT00174759Sanofi1,460
A double-blind, randomized study of clopidogrel 75... | 临床试验